Literature DB >> 18413212

TNF-alpha is an independent serum marker for proliferative retinopathy in type 1 diabetic patients.

Carin Gustavsson1, Elisabet Agardh, Boel Bengtsson, Carl-David Agardh.   

Abstract

PURPOSE: This study aimed to determine if there are any associations between serum levels of inflammatory markers and proliferative retinopathy (PDR) in type 1 diabetic patients.
DESIGN: A cross-sectional design was utilized for this study.
METHODS: One hundred twenty-eight type 1 diabetic patients underwent stereo fundus photography according to the Early Treatment Diabetic Retinopathy Study and were divided into two retinopathy groups: no or nonproliferative retinopathy (NDR/NPDR; n=62) and PDR (n=66). Serum levels of tumor necrosis factor-alpha (TNF-alpha), interleukin (IL)-1 beta, IL-6, soluble vascular cellular adhesion molecule-1 (sVCAM-1), soluble intercellular adhesion molecule-1 (sICAM-1), P-selectin, and high-sensitivity C-reactive protein (hsCRP) were analyzed. Statistical analysis was performed using nonparametric Mann-Whitney U test and multivariate logistic regression analysis.
RESULTS: Patients with PDR had higher levels of TNF-alpha [7.0 pg/ml (<4-17) vs. 6.0 pg/ml (<4-25); P=.009], sVCAM-1 [860 ng/ml (360-2120) vs. 700 ng/ml (310-1820); P<.001], and P-selectin [180 ng/ml (39-400) vs. 150 ng/ml (42-440); P=.017; figures are expressed as median (range)]. There were no differences in serum levels of sICAM-1 or hsCRP. IL-1 beta was not detectable in any patient, and IL-6 was detectable in only 22.7% of the patients. In multivariate logistic regression analysis, TNF-alpha was the single, persistent, independent determinant inflammatory marker for PDR.
CONCLUSION: The association between TNF-alpha and PDR in type 1 diabetic patients suggests that inflammation might play a role in the pathogenesis of proliferative diabetic retinopathy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18413212     DOI: 10.1016/j.jdiacomp.2007.03.001

Source DB:  PubMed          Journal:  J Diabetes Complications        ISSN: 1056-8727            Impact factor:   2.852


  36 in total

1.  Angiogenic Factors and Cytokines in Diabetic Retinopathy.

Authors:  Steven F Abcouwer
Journal:  J Clin Cell Immunol       Date:  2013

2.  Matrix metalloproteinase-10 plays an active role in microvascular complications in type 1 diabetic patients.

Authors:  Marta Toni; José Hermida; María J Goñi; Patricia Fernández; William C Parks; Estefanía Toledo; Ramón Montes; Nieves Díez
Journal:  Diabetologia       Date:  2013-12       Impact factor: 10.122

3.  The predictive role of markers of Inflammation and endothelial dysfunction on the course of diabetic retinopathy in type 1 diabetes.

Authors:  Hussein A Rajab; Nathaniel L Baker; Kelly J Hunt; Richard Klein; Patricia A Cleary; John Lachin; Gabriel Virella; Maria F Lopes-Virella
Journal:  J Diabetes Complications       Date:  2014-08-20       Impact factor: 2.852

4.  P-selectin Plasma Levels and Genetic Variant Associated With Diabetic Retinopathy in African Americans.

Authors:  Alan Penman; Suzanne Hoadley; James G Wilson; Herman A Taylor; Ching J Chen; Lucia Sobrin
Journal:  Am J Ophthalmol       Date:  2015-03-17       Impact factor: 5.258

Review 5.  Positive psychological characteristics in diabetes: a review.

Authors:  Christopher M Celano; Eleanor E Beale; Shannon V Moore; Deborah J Wexler; Jeff C Huffman
Journal:  Curr Diab Rep       Date:  2013-12       Impact factor: 4.810

6.  Prospective study of inflammatory biomarkers and risk of diabetic retinopathy in the diabetes control and complications trial.

Authors:  Rajeev H Muni; Radha P Kohly; Eudocia Q Lee; JoAnn E Manson; Richard D Semba; Debra A Schaumberg
Journal:  JAMA Ophthalmol       Date:  2013-04       Impact factor: 7.389

Review 7.  Vasoregression: A Shared Vascular Pathology Underlying Macrovascular And Microvascular Pathologies?

Authors:  Akanksha Gupta; Sonika Bhatnagar
Journal:  OMICS       Date:  2015-12

8.  The rs3917779 polymorphism of P-selectin's significant association with proliferative diabetic retinopathy in Yazd, Iran.

Authors:  Parisa Kolahdouz; Ehsan Farashahi Yazd; Masoud Tajamolian; Masoud Reza Manaviat; Mohammad Hasan Sheikhha
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-09-07       Impact factor: 3.117

9.  Inflammatory biomarkers and progression of diabetic retinopathy in African Americans with type 1 diabetes.

Authors:  Monique S Roy; Malvin N Janal; Juan Crosby; Robert Donnelly
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-08-13       Impact factor: 4.799

10.  m-Coumaric acid attenuates non-catalytic protein glycosylation in the retinas of diabetic rats.

Authors:  Said Salama Moselhy; Syed Shoeb Razvi; Fawzia A ALshibili; Abudukadeer Kuerban; Mohammed Nihal Hasan; Khadijah Saeed Balamash; Etimad A Huwait; Wesam H Abdulaal; Maryam A Al-Ghamdi; Taha A Kumosani; Khalid Omar Abulnaja; Abdulrahman L Al-Malki; Tadao Asami; Iman M Ismail
Journal:  J Pestic Sci       Date:  2018-08-20       Impact factor: 1.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.